Viewing StudyNCT00148681



Ignite Creation Date: 2024-05-05 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00148681
Status: COMPLETED
Last Update Posted: 2019-01-15
First Post: 2005-09-07

Brief Title: Preoperative Herceptin and Navelbine for Breast Cancer
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Organization Data

Organization: Dana-Farber Cancer Institute
Class: OTHER
Study ID: 00-273
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Dana-Farber Cancer Institute
Lead Sponsor Class: OTHER
Responsible Party: Eric P Winer MD
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Dana-Farber Cancer Institute
Old Name: None
Old Organization: None

Collaborators

Name Class
Brigham and Womens Hospital OTHER
Massachusetts General Hospital OTHER
Beth Israel Deaconess Medical Center OTHER